- Tonix Pharmaceuticals (NASDAQ:TNXP) prices its public offering of 4.9M shares of common stock at $5.85 per share. Underwriters over-allotment is an additional 735K shares. Closing date is February 9.
- Net proceeds of ~$26.7M will fund the continued development of TNX-102 SL, TNX-201, other pipeline programs, working capital and general corporate purposes.
Tonix Pharma prices equity offering
Recommended For You
About TNXP Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
TNXP | - | - |
Tonix Pharmaceuticals Holding Corp. |